Suppr超能文献

A型肉毒杆菌毒素用于面部年轻化。美国和英国的观点。

Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives.

作者信息

Lowe N J

机构信息

Department of Dermatology, University of California, Los Angeles, School of Medicine, USA.

出版信息

Dermatol Surg. 1998 Nov;24(11):1216-8. doi: 10.1111/j.1524-4725.1998.tb04100.x.

Abstract

BACKGROUND

Botulinum A toxin has been well documented as a successful treatment for hyperfunctional upper facial expression lines. Currently, there are two commercial sources for botulinum toxin--Botox and Dysport. Only Botox is currently available in the United States; however, both Botox and Dysport are available in a number of European and other countries.

OBJECTIVES

There are several differences between these two sources of botulinum toxin, including different potency of their dosage units. This article will review the uses of these two sources of botulinum toxin and discuss the dilution and dosing of botulinum toxin for facial expression lines.

RESULTS

One unit of Botox is approximately equivalent in potency to 4 U of Dysport.

CONCLUSIONS

Both commercial types of botulinum toxin can be used interchangeably with appropriate dosage selection.

摘要

背景

肉毒杆菌A毒素已被充分证明是治疗面部上半部分功能亢进性表情纹的成功方法。目前,肉毒杆菌毒素有两种商业来源——保妥适(Botox)和丽舒妥(Dysport)。目前在美国只有保妥适可用;然而,保妥适和丽舒妥在许多欧洲国家和其他国家都有销售。

目的

这两种肉毒杆菌毒素来源之间存在若干差异,包括其剂量单位的效力不同。本文将综述这两种肉毒杆菌毒素来源的用途,并讨论用于面部表情纹的肉毒杆菌毒素的稀释和剂量。

结果

1个单位的保妥适效力约相当于4个单位的丽舒妥。

结论

两种商业类型的肉毒杆菌毒素在进行适当的剂量选择后可以互换使用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验